Soon after beginning to use weight loss drugs, Latisha Doty and Alison Bocking met through a TikTok GLP-1 group in 2022, and they have since found strength in each other as they deal with their weight ...

Her doctor was on board, so long as Hasan also agreed to start resistance training—something she had only done briefly in the ...

New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

Ekol International Hospitals, a leading authority in obesity treatment in Türkiye, underscores the urgent need for a holistic and personalised approach to obesity management, calling for global action ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.

US households with users of GLP-1 drugs like Ozempic spend 6-9% less on groceries, with ultra-processed foods seeing the ...

In this podcast, Motley Fool analyst Asit Sharma and host Ricky Mulvey check in on the year in investing. They discuss: What most of the biggest winners in the S&P 500 had in common. Why more ...

Kwame Raoul’s office sent cease and desist letters to five unnamed medical spas in the Chicago area that were allegedly ...

Currax Pharmaceuticals is taking a page out of Lesley Gore’s playbook to remind patients that obesity doesn’t own them. The drugmaker launched a campaign supporting its weight loss medication ...

Eli Lilly and Company has invested more than $20 billion in its manufacturing capabilities since 2020 to help meet high ...